Breaking News
Subscribe Now 0
📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI. See top stocks

Stock Markets Analysis & Opinion

Contribute
Edison
Probiodrug: Data Paint Positive Picture   By Edison - Jun 16, 2017

Probiodrug AG. (AS:PDB) presented the first data from its flagship Phase IIa clinical trial with its lead drug candidate PQ912, a glutaminyl cyclase (QC) inhibitor, for early Alzheimer’s disease...

Continue with Apple
Continue with Google
or
Sign up with Email